{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who signed an informed consent form (ICF).",
        "criteria": "Signed an informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "All participants who were enrolled in the study.",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "All enrolled participants who received at least 1 dose of study drug. This set will be used for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "All participants in the FA Set who have no major protocol deviations that would impact the primary efficacy endpoint. The specific criteria for exclusion from the PP Set will be determined and finalized prior to database lock. This set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "criteria": "In FA Set with no major protocol deviations impacting the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "description": "All enrolled participants who received at least 1 dose of study drug. This set will be used for all safety analyses.",
        "criteria": "Enrolled and received at least 1 dose of study drug"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "Pharmacokinetic",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "All participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter. This set will be used for all PK analyses.",
        "criteria": "In Safety Set with sufficient plasma concentration data for derivation of at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "Pharmacodynamic",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "All participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter. This set will be used for all PD analyses.",
        "criteria": "In Safety Set with sufficient PD data for derivation of at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age calculated from the date of birth and the date of informed consent. Summarized as a continuous variable and by age group (<18, 18 to <65, and â‰¥65 years)."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant, summarized by counts and percentages."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant, summarized by counts and percentages."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant, summarized by counts and percentages."
      },
      {
        "id": "char_5",
        "name": "Body Mass Index (BMI)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline BMI will be calculated using the height and weight measurements from the Screening visit."
      },
      {
        "id": "char_6",
        "name": "Duration of Wilson Disease (WD)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Duration of Wilson Disease at baseline."
      },
      {
        "id": "char_7",
        "name": "Baseline copper balance",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline copper balance measurement."
      },
      {
        "id": "char_8",
        "name": "Baseline molybdenum balance",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline molybdenum balance measurement."
      },
      {
        "id": "char_9",
        "name": "Baseline ceruloplasmin",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory value for ceruloplasmin."
      },
      {
        "id": "char_10",
        "name": "Baseline non-ceruloplasmin-bound copper (NCC)",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Baseline laboratory value for non-ceruloplasmin-bound copper (NCC)."
      },
      {
        "id": "char_11",
        "name": "Medical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical history coded using MedDRA and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_12",
        "name": "Surgical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Surgical history coded using MedDRA and summarized by system organ class (SOC) and preferred term (PT)."
      },
      {
        "id": "char_13",
        "name": "Wilson Disease History",
        "dataType": "Text",
        "instanceType": "Characteristic",
        "description": "Summary of Wilson Disease (WD) history."
      },
      {
        "id": "char_14",
        "name": "Prior medications for Wilson Disease",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Summary of prior medications used to treat Wilson Disease (WD)."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 14
    }
  }
}